NW Recovery Centers Logo
News

U.S. Overdose Deaths Fall to Lowest Level Since 2019, But Western States Face Deadly Surge

CDC data shows overdose deaths dropped to under 70,000 in 2025 — the lowest since 2019. Alabama, New York, and Virginia see 25-30% declines, while Arizona and New Mexico experience alarming spikes.

Abstract visualization of declining overdose statistics with state map patterns

U.S. Overdose Deaths Fall to Lowest Level Since 2019, But Western States Face Deadly Surge

For the first time in decades, the United States is seeing sustained, meaningful decline in drug overdose deaths. According to provisional data from the Centers for Disease Control and Prevention (CDC), fatalities from drug overdoses fell from more than 81,000 in 2024 to just under 70,000 in the 12-month period ending December 2025 — marking the lowest level since at least 2019 and the third consecutive year of national decline.

The National Picture: Progress After Years of Crisis

The downward trend began in the summer of 2023, breaking a decades-long pattern of rising overdose deaths that had devastated communities across America. Dr. Nora Volkow, director of the National Institute on Drug Abuse (NIDA), admits that researchers initially questioned whether the improvement would last.

"We weren't certain that they were going to be sustainable," Volkow told NPR. "Not only have they been sustainable, but that decline has been higher. So this is very good news."

The 14% national decrease represents approximately 11,000 fewer deaths — a significant public health achievement that researchers attribute to several key factors, most notably the widespread distribution of naloxone, the life-saving medication that reverses opioid overdoses.

Leaders in Recovery: Alabama, New York, and Virginia

While the national trend is encouraging, three states stand out for particularly dramatic improvements. Overdose deaths in Alabama, New York, and Virginia all declined by 25% to 30% during the reporting period.

These states have implemented comprehensive strategies that include:

  • Expanded naloxone access — Making overdose reversal medication available to first responders, community organizations, and laypeople
  • Medication-assisted treatment (MAT) expansion — Increasing access to buprenorphine, methadone, and naltrexone for opioid use disorder
  • Harm reduction programs — Syringe service programs, drug checking initiatives, and outreach to high-risk populations
  • State funding for treatment — Using opioid settlement dollars and state appropriations to expand treatment capacity

"First responders and laypeople have naloxone," notes Beth Meyerson, who studies addiction health policy at the University of Arizona College of Medicine. "We're beginning to see that naloxone is first aid, and that, I think, is absolutely critical."

The Other Side of the Crisis: Arizona and New Mexico Surge

Despite national progress, the data reveals a troubling divergence. Two western states — Arizona and New Mexico — actually saw overdose deaths increase significantly in 2025. Fatal overdoses spiked 19% in Arizona and surged more than 21% in New Mexico.

Researchers point to several factors driving these increases:

Geographic and Healthcare Access Barriers

In Arizona, rural communities face severe shortages of addiction treatment providers. Residents in some areas must travel over two hours to reach opioid use disorder treatment facilities — a barrier that can mean the difference between life and death for someone in crisis.

Disparities in Native American Communities

Both Arizona and New Mexico have substantial Native American populations, and CDC data highlights stark disparities in overdose mortality. Dr. Volkow notes that "the overdose mortality among Native Americans is double that of the general rest of the United States."

This disparity reflects historical underinvestment in healthcare infrastructure for tribal communities, limited access to culturally appropriate treatment services, and ongoing economic challenges in many Native communities.

Racial and Age Disparities Persist

The national recovery is also leaving other groups behind. Overdose fatalities remain disproportionately high in many predominantly Black communities, and older Americans have seen slower improvements compared to younger age groups.

What This Means for Families

For families navigating addiction, these trends offer both hope and caution. The national decline demonstrates that evidence-based interventions work — when they reach the people who need them.

Key Takeaways for Families:

Naloxone saves lives. The correlation between naloxone distribution and declining deaths is clear. Every household with someone using opioids — whether prescribed or illicit — should have naloxone on hand and know how to use it. Most states allow naloxone to be obtained without a prescription at pharmacies.

Treatment access matters. States that have expanded medication-assisted treatment and reduced barriers to care are seeing the strongest results. If you're seeking treatment for a loved one, prioritize programs that offer FDA-approved medications for opioid use disorder.

Rural communities face unique challenges. If you live in a rural area with limited treatment options, telehealth services can provide access to addiction specialists and medication prescribing. The DEA has extended flexibilities for telehealth prescribing of buprenorphine.

Don't assume the crisis is over. While national numbers improve, local conditions vary dramatically. Communities in Arizona, New Mexico, and other hard-hit areas still face acute risks from the fentanyl-contaminated drug supply.

Looking Forward: Sustaining Progress

Public health experts emphasize that maintaining and accelerating this progress will require continued investment in proven strategies:

  • Sustained funding for harm reduction — Despite recent federal restrictions on certain harm reduction supplies, naloxone distribution and other evidence-based programs remain critical
  • Treatment capacity expansion — Particularly in underserved rural areas and communities of color
  • Addressing health disparities — Targeted interventions for Native American communities, Black communities, and older adults
  • Fentanyl supply disruption — Law enforcement and public health collaboration to reduce the availability of ultra-potent synthetic opioids

The 2025 data represents a genuine turning point in America's overdose crisis — but one that remains fragile and unevenly distributed. For families affected by addiction, the message is clear: help is more available than ever in many communities, but vigilance and preparation remain essential.


If you or someone you love is struggling with substance use, confidential help is available 24/7 through the SAMHSA National Helpline at 1-800-662-4357.

Sources